BioXcel drug to treat Mass General COVID-19 patients
Massachusetts General Hospital will use a New Haven biotechnology company’s experimental agitation drug to treat symptoms of “ICU delirium” in critically ill patients hospitalized with...
Home >
Access the latest news, business developments, company updates, industry trends, events and more.
Massachusetts General Hospital will use a New Haven biotechnology company’s experimental agitation drug to treat symptoms of “ICU delirium” in critically ill patients hospitalized with...
Healing broken bones could get easier with a device that provides both a scaffold for the bone to grow on and electrical stimulation to urge...
Twenty of the world’s largest pharmaceutical companies on Thursday announced the creation of a $1 billion fund to buoy financially strapped biotech start-ups that are...
Pfizer and BioNTech report that two of the companies’ four investigational vaccine candidates from their BNT162 mRNA-based vaccine program (BNT162b1 and BNT162b2) being developed to...
Kleo Pharmaceuticals, the five-year-old New Haven biotech based in Science Park, has secured a $5 million grant from the Bill & Melinda Gates Foundation for its...
Cybrexa Therapeutics has successfully completed a pre-IND (Investigational New Drug) meeting with the U.S. Food and Drug Administration (FDA) regarding its proposed IND and Phase I/II...
CRISPR methods have made genome engineering accurate and efficient. A team at The Jackson Laoratory led by Albert Cheng has developed a new method, CASFx,...
Arvinas reports that Wendy Dixon, Ph.D., has joined its Board of Directors. Dr. Dixon is a well-respected leader with 40 years of broad and deep...
As the coronavirus pandemic has reshuffled the economic landscape across the country, Connecticut is targeting small companies with top executives who may have grown tired...
Cybrexa Therapeutics has successfully completed a pre-IND (Investigational New Drug) meeting with the U.S. Food and Drug Administration (FDA) regarding its proposed IND and Phase I/II...